Federal contract receipt
$128,996,651 from Department of Health and Human Services to AMGEN USA INC
TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.
Signals
Full and openLarge awardMulti-year performance
Office of Federal Procurement Policy
Public Spend Intelligence - sledai.com
Award #CONT_AWD_75A50122C00065_7505_-NONE-_-NONE-
Signed2024-09-27
VendorAMGEN USA INC
PlaceCA
TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.
Total obligated$128,996,650.88
PoP Start
2022-09-30
PoP End
2032-09-29
COMPETED
Awarded on 2024-09-27
Vendor
AMGEN USA INC
Agency
Department of Health and Human Services
Category
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Place
CA
© 2025 Sled AI Inc. All rights reserved.